Product and solution innovation
Ve společnosti Cencora upřednostňujeme lidi na prvním místě, a proto kombinujeme hluboké odborné znalosti a nejlepší technologie, které může toto odvětví nabídnout, abychom podpořili naše zákazníky při vývoji zdravotnického průmyslu. Jsme hrdí na to, že pracujeme co nejblíže zákazníkovi – opíráme se o náš talent, úsudek a osobní zapojení a přinášíme na stůl model rozšířený o odborné znalosti, který je těžké replikovat.
Lidské odborné znalosti se setkávají s novými technologiemi a vytvářejí globální inovace, které se škálují
Our Global Products and Solutions team works closely with partners around the world to gain insight into the challenges they face today, as well as the opportunities that lie ahead.
Our drive towards innovation is rooted in our commitment to lower the cost and time in which new therapies come to market. Offerings in development and scaling span our core capabilities in distribution and inventory management and expand to new services based on our access to robust data across the value chain.
We are excited to be developing offerings to meet the needs of our customers and pave the way for more efficient healthcare delivery for years to come.
Our drive towards innovation is rooted in our commitment to lower the cost and time in which new therapies come to market. Offerings in development and scaling span our core capabilities in distribution and inventory management and expand to new services based on our access to robust data across the value chain.
We are excited to be developing offerings to meet the needs of our customers and pave the way for more efficient healthcare delivery for years to come.
"Global Products and Solutions is such a dynamic team, where innovation and collaboration are propelling us to new heights. Together, we cultivate an environment that not only embraces change but thrives on it. By optimizing the way we work, we are able to facilitate faster and more effective concept-to-launch processes that drive impactful results for the communities we serve."
Tina Martinez
Vice President, Head of Global Products and Solutions
Tina Martinez
Vice President, Head of Global Products and Solutions
Naše hlavní inovace
Následující produkty a řešení jsou v současné době v různých fázích vývoje. Podívejte se, co zajímavého společnost Cencora chystá.
Klinická hodnocení a distribuce
Výrobci, smluvní výzkumné organizace a farmaceutické společnosti zajišťující výrobu a vývoj na zakázku
Řešení využívající naše farmaceutické partnery a globální síť skladů k efektivnímu a nákladově efektivnímu nákupu, řízení a dodávání produktů pro klinické studie a srovnávací přípravky.
Přetváříme způsob poskytování zdravotní péče pomocí spolehlivých, adaptivních systémů a řešení vytvořených a testovaných tak, aby splňovaly všechny výzvy, kterým čelíme.
Náš tým globálních produktů a řešení úzce spolupracuje s partnery po celém světě, aby lépe porozuměl jejich současným výzvám, identifikoval příležitosti na obzoru a vyvinul nabídky, které vydláždí cestu k efektivnějšímu poskytování zdravotní péče.
Product manager spotlight
Elisa Moxley
Vice President, Product Development
What did you study in school and what did you think you were going to be when you grew up?
I double majored in business and psychology in undergrad and have an MBA with a concentration in marketing. My career goal changed as I was growing up but through college, I thought I would end up in marketing. Regardless of the roles I’ve held over the past years, I find that my psychology degree has been incredibly beneficial as I work and collaborate across different teams and departments.
What strategies do you use to identify and prioritize customer needs when developing new products?
First and foremost is using customer feedback, whether through surveys, interviews, or discussions, to clearly understand what needs and the job to be done. Factors considered as part of prioritization is ease of build, size of market and need, organizational strategy, and value or impact to customer.
What product are you working on right now and why is it important?
The product I am working on is Dedicated Virtual Warehouse (DVW), which virtually sequesters product on behalf of our downstream customers. This product is important as it helps provide more transparency and inventory control, which ultimately helps support supply chain resiliency and product availability.
I double majored in business and psychology in undergrad and have an MBA with a concentration in marketing. My career goal changed as I was growing up but through college, I thought I would end up in marketing. Regardless of the roles I’ve held over the past years, I find that my psychology degree has been incredibly beneficial as I work and collaborate across different teams and departments.
What strategies do you use to identify and prioritize customer needs when developing new products?
First and foremost is using customer feedback, whether through surveys, interviews, or discussions, to clearly understand what needs and the job to be done. Factors considered as part of prioritization is ease of build, size of market and need, organizational strategy, and value or impact to customer.
What product are you working on right now and why is it important?
The product I am working on is Dedicated Virtual Warehouse (DVW), which virtually sequesters product on behalf of our downstream customers. This product is important as it helps provide more transparency and inventory control, which ultimately helps support supply chain resiliency and product availability.
Novinky
Přečtěte si naše nejnovější oznámení o řešeních uvedených na trh, partnerstvích, investicích a dalších tématech.
Other Cencora teams dedicated to innovation
Cencora Ventures ®
We support the growth of leading-edge entrepreneurial businesses through our $150 million corporate venture fund focused on pharmaceutical and biopharma innovation. This team invests in and provides commercial support to emerging healthcare startup companies to help them maintain scalability as they grow.
Cell and Gene therapy (CGT)
New advances are being made in medicine every day, and our goal is to facilitate those innovations so patients who need them have access. This is complicated for specialty therapeutics like cell and gene therapy, so we have a team focused on innovating in step with our partners in this space.
